Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: T74V9O0Y2W

Structure

InChI Key JYILLRHXRVTRSH-GFCCVEGCSA-N
Smile O=C(Nc1ccccc1Br)N[C@@H]1CCN(c2ccc(C(F)(F)F)cn2)C1
InChI
InChI=1S/C17H16BrF3N4O/c18-13-3-1-2-4-14(13)24-16(26)23-12-7-8-25(10-12)15-6-5-11(9-22-15)17(19,20)21/h1-6,9,12H,7-8,10H2,(H2,23,24,26)/t12-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H16BrF3N4O
Molecular Weight 429.24
AlogP 4.26
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 3.0
Polar Surface Area 57.26
Molecular species NEUTRAL
Aromatic Rings 2.0
Heavy Atoms 26.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Vanilloid receptor antagonist PubMed
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Ion channel Voltage-gated ion channel Transient receptor potential channel
- 100 - - 102

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Irritable Bowel Syndrome 2 D043183 ClinicalTrials
Migraine Disorders 2 D008881 ClinicalTrials
Rhinitis 2 D012220 ClinicalTrials
Toothache 2 D014098 ClinicalTrials
Dermatitis, Atopic 1 D003876 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 501951-42-4
ChEMBL CHEMBL207433
DrugBank DB11883
EPA CompTox DTXSID20198236
FDA SRS T74V9O0Y2W
Guide to Pharmacology 4311
PubChem 9910486
SureChEMBL SCHEMBL1350298
ZINC ZINC000013985502